Insights

Innovative Technology Platforms Phanes Therapeutics specializes in advanced bispecific antibody platforms, PACbodyTM and ATACCbodyTM, which present opportunities for collaborations with biotech and pharmaceutical companies seeking innovative immuno-oncology solutions or therapies for eye diseases.

Growing Clinical Pipeline With several clinical-stage assets like PT886 and PT217 progressing through Phase 1 trials, there is potential for partnership or licensing deals with organizations interested in early-stage oncology treatments targeting gastric, pancreatic, and neuroendocrine cancers.

Recent Strategic Collaborations The company's recent partnership with Xyphos Biosciences and its presentation at ASCO GI 2026 indicate a focus on expanding its research collaborations and visibility within oncology circles, creating opportunities for joint development and strategic alliances.

Funding and Growth Potential Backed by a $40M Series B investment from Sequoia Capital China, Phanes has the financial backing to accelerate its drug discovery efforts, making it an attractive candidate for investors or partners seeking innovative biotech ventures with high growth potential.

Target Market Opportunities With a focus on immuno-oncology and neuroendocrine cancers, Phanes’ pipeline aligns with current market trends favoring targeted therapies for hard-to-treat cancers, presenting sales opportunities to pharma companies expanding their oncology portfolios with novel, bispecific antibody therapies.

Phanes Therapeutics, Inc. Tech Stack

Phanes Therapeutics, Inc. uses 8 technology products and services including Open Graph, Shopify, Font Awesome, and more. Explore Phanes Therapeutics, Inc.'s tech stack below.

  • Open Graph
    Content Management System
  • Shopify
    E-commerce
  • Font Awesome
    Font Scripts
  • React
    Javascript Frameworks
  • Lodash
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • ReCaptcha v2 for Contact Form 7
    Web Platform Extensions
  • Apache HTTP Server
    Web Servers

Media & News

Phanes Therapeutics, Inc.'s Email Address Formats

Phanes Therapeutics, Inc. uses at least 1 format(s):
Phanes Therapeutics, Inc. Email FormatsExamplePercentage
FLast@phanesthera.comJDoe@phanesthera.com
45%
First.Last@phanesthera.comJohn.Doe@phanesthera.com
5%
FLast@phanesthera.comJDoe@phanesthera.com
45%
First.Last@phanesthera.comJohn.Doe@phanesthera.com
5%

Frequently Asked Questions

Where is Phanes Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Phanes Therapeutics, Inc.'s main headquarters is located at 10675 Sorrento Valley Rd Suite 100 San Diego, California 92121 US. The company has employees across 1 continents, including North America.

What is Phanes Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Phanes Therapeutics, Inc.'s official website is phanesthera.com and has social profiles on LinkedIn.

What is Phanes Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Phanes Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Phanes Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of May 2021, Phanes Therapeutics, Inc. has approximately 12 employees across 1 continents, including North America. Key team members include Operations Manager: E. H.. Explore Phanes Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Phanes Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Phanes Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Phanes Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Phanes Therapeutics, Inc.'s tech stack includes Open GraphShopifyFont AwesomeReactLodashMicrosoft WordReCaptcha v2 for Contact Form 7Apache HTTP Server.

What is Phanes Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Phanes Therapeutics, Inc.'s email format typically follows the pattern of FLast@phanesthera.com. Find more Phanes Therapeutics, Inc. email formats with LeadIQ.

Phanes Therapeutics, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

Phanes Therapeutics, Inc. is a biotech company focused on innovative drug discovery and early development in immuno-oncology and eye disease. Our mission is to become a major source of innovation in the biopharma industry. The way we focus on science, the disruptive technologies we develop, and the revolutionary approaches we bring help open up new possibilities in drug discovery. At Phanes, we bring innovation that illuminates the path to cure.

Phanes' two technology platforms are designed to build native IgG-like bispecific antibodies that enhance drug-like properties.

PACbodyTM: Build native IgG-like bispecific antibodies.
ATACCbodyTM: Build bispecific antibodies with modulated activities.

Section iconCompany Overview

Headquarters
10675 Sorrento Valley Rd Suite 100 San Diego, California 92121 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $1M

    Phanes Therapeutics, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Phanes Therapeutics, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.